Variables | Patients | Controls | Test value | P-value | |
n = 60 | n = 20 | ||||
Age (years) | Mean ± SD | 52.32 ± 7.23 | 51.25 ± 8.39 | −0.549• | 0.585 |
Range | 36 - 68 | 32 - 65 | |||
Sex (n, %) | Female | 28 (46.7%) | 12 (60.0%) | 1.067* | 0.302 |
Male | 32 (53.3%) | 8 (40.0%) | |||
sUPAR (ng/L) | Median IQR | 178.35 152.45 - 240.7 | 132.70 110.3 - 160.3 | −3.889¥ | <0.001 |
IL-34 (ng/L) | Median IQR | 22.80 16.35 - 112.8 | 14.15 12.65 - 16.35 | −4.439¥ | <0.001 |
WBCs (×109/L) | Mean ± SD | 6.35 ± 2.20 | 6.99 ± 1.59 | 1.208• | 0.231 |
Range | 2.3 - 10.9 | 4.9 - 10 | |||
Hb (g/dL) | Mean ± SD | 12.34 ± 1.81 | 13.83 ± 1.60 | 3.255• | 0.002 |
Range | 8.2 - 17 | 10.3 - 15.9 | |||
PLT (×109/L) | Mean ± SD | 181.62 ± 86.61 | 272.10 ± 59.16 | 4.338• | <0.001 |
Range | 59 - 469 | 191 - 410 | |||
ALT (U/L) | Median | 43.00 | 31.00 | −2.973¥ | 0.003 |
IQR | 28.5 - 69.5 | 26.5 - 34 | |||
AST (U/L) | Median | 47.25 | 19.00 | −5.857¥ | <0.001 |
IQR | 30 - 66 | 15.5 - 21.5 | |||
FIB-4 score | Median | 2.26 | 0.66 |
|
|
IQR | 1.15 - 3.58 | 0.44 - 0.82 | −5.822¥ | <0.001 |